» Authors » Hideki Okayama

Hideki Okayama

Explore the profile of Hideki Okayama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 108
Citations 875
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ozaki Y, Tobe A, Onuma Y, Kobayashi Y, Amano T, Muramatsu T, et al.
Cardiovasc Interv Ther . 2024 Sep; 39(4):335-375. PMID: 39302533
Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST-segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of...
2.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, et al.
J Cardiol . 2024 May; 84(5):342-344. PMID: 38735384
No abstract available.
3.
Fukumoto Y, Tada T, Suzuki H, Nishimoto Y, Moriuchi K, Arikawa T, et al.
Circ J . 2024 Apr; 88(5):692-702. PMID: 38569914
Background: This study investigated whether the chronic use of adaptive servo-ventilation (ASV) reduces all-cause mortality and the rate of urgent rehospitalization in patients with heart failure (HF). Methods and results:...
4.
Obayashi Y, Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Nishikawa R, et al.
Eur Heart J Cardiovasc Pharmacother . 2024 Jan; 10(5):374-390. PMID: 38285607
Background And Aims: High bleeding risk (HBR) and acute coronary syndrome (ACS) subtypes are critical in determining bleeding and cardiovascular event risk after percutaneous coronary intervention (PCI). Methods And Results:...
5.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Nishikawa R, et al.
J Am Coll Cardiol . 2023 Oct; 83(1):17-31. PMID: 37879491
Background: It remains unclear whether clopidogrel is better suited than aspirin as the long-term antiplatelet monotherapy following dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Objectives: This study compared...
6.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Nakamura S, et al.
JACC Asia . 2023 Aug; 3(4):649-661. PMID: 37614540
Background: There are no studies comparing single-session vs staged multivessel intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with chronic coronary syndrome (CCS) or non-ST-segment-elevation acute coronary syndrome (NSTE-ACS)....
7.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Nakamura S, et al.
Circ J . 2023 May; 87(11):1661-1671. PMID: 37197941
Background: There is a scarcity of data evaluating contemporary real-world dual antiplatelet therapy (DAPT) strategies after percutaneous coronary intervention (PCI). Methods and results: In the OPTIVUS-Complex PCI study multivessel cohort...
8.
Yamamoto K, Shiomi H, Morimoto T, Miyazawa A, Watanabe H, Natsuaki M, et al.
Circ Cardiovasc Interv . 2023 May; 16(5):e012922. PMID: 37192307
Background: Several stent expansion criteria derived from the intravascular ultrasound (IVUS) evaluation have been proposed to predict future clinical outcomes, but optimal stent expansion criteria as a guide during percutaneous...
9.
Yamamoto K, Shiomi H, Morimoto T, Watanabe H, Miyazawa A, Yamaji K, et al.
JACC Asia . 2023 May; 3(2):211-225. PMID: 37181400
Background: Intravascular ultrasound (IVUS) was only rarely used in landmark trials comparing percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in patients with multivessel disease. Objectives: The authors...
10.
Yamamoto K, Shiomi H, Morimoto T, Watanabe H, Miyazawa A, Yamaji K, et al.
Circ J . 2023 Mar; 87(11):1689-1702. PMID: 36908119
Background: There is a paucity of data on the effect of optimal intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) compared with standard PCI or coronary artery bypass grafting (CABG) in...